by 
Share On Social!
In clinical trials, researchers test life-saving treatments and find ways to prevent and manage disease.
But Latinos don’t often participate in research.
They account for less than 10% of people in federal cancer clinical trials. This makes it hard for researchers to create treatments that work best for Latinos.
This is the focus of a new webinar, “Addressing Clinical Trial Enrollment Barriers in Unique Populations,” set for 1 p.m. ET Wednesday, April 21, 2021. The event is sponsored by Fight Colorectal Cancer.
Panelists are:
- Amelie G. Ramirez, DrPh, is Director of the Salud America! program and its new project to engage more Latinos in cancer and Alzheimer’s research (supported by a grant from Genentech, a member of the Roche Group), Professor and Chair of the Department of Population Health Sciences, and Director of the Institute for Health Promotion Research, all at UT Health San Antonio
- Dr. Edith Mitchell, MD, Retired Brigadier General of the U.S. Air Force and Clinical Professor of Medicine and Medical Oncology at Thomas Jefferson University
- Wyatt Pickner, MPH, American Indian Cancer Foundation
Michael Marosits, patient education manager at Fight Colorectal Cancer, will moderate the webinar.
“[Join this] engaging webinar that explores barriers and access to colorectal cancer clinical trials for communities who are underrepresented in clinical trial enrollment,” Marosits said.
Learn more about clinical trials and why they are important for Latinos:
By The Numbers
142
Percent
Expected rise in Latino cancer cases in coming years
